D&P Bioinnovations, LLC is a regenerative medicine startup focused on repairing damaged organs. We are developing an implantable, bioresorbable "off-the-shelf" medical device to regenerate a damaged esophagus (organ providing food to the stomach). This device will address a $750 million U.S. annual market to treat advanced Barrett's Esophagus, esophageal cancer, birth defects of the esophagus, and fatal cases of caustic ingestion.